Dr. Yuhua Zhang 张宇华
Chief Physician
Department of Hepatobiliary and Pancreatic Surgery, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive hepatobiliary and pancreatic surgery, including laparoscopic and robotic procedures. Treatment of primary and metastatic liver cancer, pancreatic cancer, and intra- and extrahepatic bile duct stones.
Dr. Zhang holds a medical doctorate and serves as Deputy Department Director and master’s supervisor. After graduating from Zhejiang University in 2006, Dr. Zhang earned a medical degree at Charité – Universitätsmedizin Berlin (2011–2013), training under Professors Peter Neuhaus and H-J Buhr. In 2015, Dr. Zhang visited the University of Tokyo to study surgical treatment of hepatobiliary and pancreatic malignancies.
Name order: in Chinese the family name comes first (Zhang Yuhua). Papers usually list the name as Yuhua Zhang or Zhang Y.
Selected publications
35 papers on PubMed matched by name and affiliation; 13 as first or senior author since 2016. Most recent first- or senior-author papers:
- Pharmacol Res, 2026 (senior author): Inhibiting calreticulin palmitoylation enhances the efficacy of elesclomol-CuCl(2) on oxaliplatin-triggered immunogenic cell death in pancreatic cancer. PubMed 42744192
- Adv Mater, 2026 (senior author): Time-Encoded Geometric Encryption Enabled by Shape-Memory Hydrogel with Photoisomerization-Gated Autonomous Recovery. PubMed 42411139
- Life Sci, 2026 (senior author): Advances in AI for predicting pharmacological properties of natural medicines. PubMed 41475482
- Oncogene, 2025 (senior author): Alcohol-induced C/EBP β-driven VIRMA decreases oxidative stress and promotes pancreatic ductal adenocarcinoma growth and metastasis via the m6A/YTHDF2/SLC43A2 pathway. PubMed 39900725
- Clin Epigenetics, 2024 (senior author): Single-cell transcriptomics reveal the prognostic roles of epithelial and T cells and DNA methylation-based prognostic models in pancreatic cancer. PubMed 39709423
- BMC Microbiol, 2024 (senior author): Alterations of the bile microbiome is associated with progression-free survival in pancreatic ductal adenocarcinoma patients. PubMed 38956452
- Nat Commun, 2023 (senior author): 3D printing of self-healing personalized liver models for surgical training and preoperative planning. PubMed 38114507
- Biosci Trends, 2023 (senior author): 2-4 weeks is the optimal time to operate on colorectal liver metastasis after neoadjuvant chemotherapy. PubMed 37088556
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion